176 related articles for article (PubMed ID: 21565289)
41. Immunoreactive Coxiella burnetii Nine Mile proteins separated by 2D electrophoresis and identified by tandem mass spectrometry.
Deringer JR; Chen C; Samuel JE; Brown WC
Microbiology (Reading); 2011 Feb; 157(Pt 2):526-542. PubMed ID: 21030434
[TBL] [Abstract][Full Text] [Related]
42. Study of the whole cell lysate of two Coxiella burnetii strains using N-terminomics.
Papadioti A; De Bock PJ; Vranakis I; Tselentis Y; Gevaert K; Psaroulaki A; Tsiotis G
J Proteome Res; 2012 Jun; 11(6):3150-9. PubMed ID: 22559236
[TBL] [Abstract][Full Text] [Related]
43. Coxiella burnetii immunogenic proteins as a basis for new Q fever diagnostic and vaccine development.
Gerlach C; Škultéty Ľ; Henning K; Neubauer H; Mertens K
Acta Virol; 2017; 61(3):377-390. PubMed ID: 28854806
[TBL] [Abstract][Full Text] [Related]
44. Differentiation of Coxiella burnetii by sequence analysis of the gene (com1) encoding a 27-kDa outer membrane protein.
Zhang GQ; To H; Yamaguchi T; Fukushi H; Hirai K
Microbiol Immunol; 1997; 41(11):871-7. PubMed ID: 9444329
[TBL] [Abstract][Full Text] [Related]
45. Unveiling promising immunogenic targets in Coxiella burnetii through in silico analysis: paving the way for novel vaccine strategies.
Kodori M; Amani J; Ahmadi A
BMC Infect Dis; 2023 Dec; 23(1):902. PubMed ID: 38129801
[TBL] [Abstract][Full Text] [Related]
46. Comparative virulence of diverse Coxiella burnetii strains.
Long CM; Beare PA; Cockrell DC; Larson CL; Heinzen RA
Virulence; 2019 Dec; 10(1):133-150. PubMed ID: 30782062
[TBL] [Abstract][Full Text] [Related]
47. Genetic diversity of the Q fever agent, Coxiella burnetii, assessed by microarray-based whole-genome comparisons.
Beare PA; Samuel JE; Howe D; Virtaneva K; Porcella SF; Heinzen RA
J Bacteriol; 2006 Apr; 188(7):2309-24. PubMed ID: 16547017
[TBL] [Abstract][Full Text] [Related]
48. Coxiella burnetii glycomics and proteomics--tools for linking structure to function.
Toman R; Skultety L; Ihnatko R
Ann N Y Acad Sci; 2009 May; 1166():67-78. PubMed ID: 19538265
[TBL] [Abstract][Full Text] [Related]
49. The 75-kD tumour necrosis factor (TNF) receptor is specifically up-regulated in monocytes during Q fever endocarditis.
Ghigo E; Capo C; Amirayan N; Raoult D; Mege J
Clin Exp Immunol; 2000 Aug; 121(2):295-301. PubMed ID: 10931145
[TBL] [Abstract][Full Text] [Related]
50. Immunochemical and antigenic characterization of Coxiella burnetii strains isolated in Europe and Mongolia.
Kovácová E; Vavreková M; Lukácová M; Daiter AB; Tokarevich NK; Karceva NA; Gorbachev EN; Urvolgyi J; Kocianová E; Rehácek J
Eur J Epidemiol; 1994 Feb; 10(1):9-15. PubMed ID: 7957797
[TBL] [Abstract][Full Text] [Related]
51. Immunological consequences of Coxiella burnetii phase variation.
Quevedo Diaz MA; Lukácová M
Acta Virol; 1998 Jun; 42(3):181-5. PubMed ID: 9842448
[TBL] [Abstract][Full Text] [Related]
52. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis.
Rolain JM; Mallet MN; Raoult D
J Infect Dis; 2003 Nov; 188(9):1322-5. PubMed ID: 14593588
[TBL] [Abstract][Full Text] [Related]
53. Coxiella burnetii Induces Inflammatory Interferon-Like Signature in Plasmacytoid Dendritic Cells: A New Feature of Immune Response in Q Fever.
Ka MB; Mezouar S; Ben Amara A; Raoult D; Ghigo E; Olive D; Mege JL
Front Cell Infect Microbiol; 2016; 6():70. PubMed ID: 27446817
[TBL] [Abstract][Full Text] [Related]
54. The contribution of proteomics towards deciphering the enigma of Coxiella burnetii.
Vranakis I; Papadioti A; Tselentis Y; Psaroulaki A; Tsiotis G
Proteomics Clin Appl; 2013 Jan; 7(1-2):193-204. PubMed ID: 23255407
[TBL] [Abstract][Full Text] [Related]
55. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
[TBL] [Abstract][Full Text] [Related]
56. Cloning and Expression of Com1 and OmpH Genes of Coxiella burnetii in Periplasmic Compartment of Escherichia coli with the Aim of Recombinant Subunit Vaccine Production.
Bakhteyari H; Jahangir R; Nazifi N; Kakanezhadifard A; Soleimani Z; Forouharmehr A; Azadi Chegeni S; Jaydari A
Arch Razi Inst; 2019 Dec; 74(4):341-347. PubMed ID: 31939250
[TBL] [Abstract][Full Text] [Related]
57. Q fever--selected issues.
Bielawska-Drózd A; Cieślik P; Mirski T; Bartoszcze M; Knap JP; Gaweł J; Żakowska D
Ann Agric Environ Med; 2013; 20(2):222-32. PubMed ID: 23772566
[TBL] [Abstract][Full Text] [Related]
58. Protein candidates for Q fever serodiagnosis.
Kowalczewska M; Nappez C; Vincentelli R; La Scola B; Raoult D
FEMS Immunol Med Microbiol; 2012 Feb; 64(1):140-2. PubMed ID: 22098576
[TBL] [Abstract][Full Text] [Related]
59. Q fever endocarditis associated with extensive serological cross-reactivity.
Graham JV; Baden L; Tsiodras S; Karchmer AW
Clin Infect Dis; 2000 Mar; 30(3):609-10. PubMed ID: 10722459
[No Abstract] [Full Text] [Related]
60. Long-term persistence after acute Q fever of non-infective Coxiella burnetii cell components, including antigens.
Sukocheva OA; Marmion BP; Storm PA; Lockhart M; Turra M; Graves S
QJM; 2010 Nov; 103(11):847-63. PubMed ID: 20639288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
